Alaska Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• REDEFINE 1 and REDEFINE 2: Greater Weight Loss With Combined Cagrilintide-Semaglutide vs. Either Drug Alone or Placebo
  The combination of cagrilintide with semaglutide (CagriSema) in a single weekly injection was associated with a significantly greater weight loss in adults with overweight or obesity regardless of type 2 diabetes (T2D) status compared with placebo or either drug alone...
• Starting DOACs Early After Stroke Lowers Risk of Future Strokes, Hemorrhage
  Initiating direct oral anticoagulants (DOACs) within four days, rather than at five days or later, after an ischemic stroke in patients with atrial fibrillation (AFib) reduced the risk of future stroke events within 30 days without increasing symptomatic intracerebral hemorrhage...
• Poll: Transcatheter Mitral Valve Replacement in a High Surgical Risk Patient With Mitral Stenosis
  Mrs. M is an 81-year-old female patient who presents with worsening exertional dyspnea. She has a history of type 2 diabetes mellitus, heart failure with preserved ejection fraction, and prior surgical aortic valve replacement in the setting of severe symptomatic aortic stenosis.
• PRAGUE-25: What Is the Best Intervention Strategy For AFib In Obesity?
  Catheter ablation (CA) was superior to a combination of lifestyle modification (LFM) and antiarrhythmic drugs (AADs) in improving freedom from atrial fibrillation (AFib) at one year in patients with obesity, according to results from the PRAGUE-25 trial published in JACC.
• June AMA House of Delegates Key Takeaways
  The American Medical Association (AMA) House of Delegates met in June to discuss and vote on the latest round of proposed resolutions aimed at guiding AMA’s policies on key medical, ethical and public health issues.